hydrocortisone sodium succinate
hydrocortisone sodium succinate.JPG

hydrocortisone sodium succinate

CLINICAL USE

Corticosteroid:Anti-inflammatory agent in respiratory, GI, endocrine disorders, and allergic statesShock

DOSE IN NORMAL RENAL FUNCTION

Oral: 20–30 mg in divided doses for replacementIV/IM: 100–500 mg, 3–4 times in 24 hours, or as required

PHARMACOKINETICS

  • Molecular weight                           :484.5 (486.4 as sodium phosphate)
  • %Protein binding                           :>90
  • %Excreted unchanged in urine     : Minimal
  • Volume of distribution (L/kg)       :0.4–0.7
  • half-life – normal/ESRD (hrs)      :Approx 100 minutes/ Unchanged

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Unlikely to be dialysed. Dose as in normal renal function
  • HD                     :Unlikely to be dialysed. Dose as in normal renal function
  • HDF/high flux   :Unlikely to be dialysed. Dose as in normal renal function
  • CAV/VVHD      :Unlikely to be dialysed. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • Antibacterials: metabolism accelerated by rifampicin; metabolism possibly inhibited by erythromycin
  • Anticoagulants: efficacy of coumarins may be altered
  • Anti-epileptics: metabolism accelerated by carbamazepine, barbiturates, phenytoin and primidone
  • Antifungals: increased risk of hypokalaemia with amphotericin – avoid concomitant use; metabolism possibly inhibited by itraconazole and ketoconazole
  • Antivirals: concentration possibly increased by ritonavir
  • Ciclosporin: rare reports of convulsions in patients on ciclosporin and high-dose corticosteroidsCytotoxics: increased risk of haematological toxicity with methotrexate
  • Diuretics: enhanced hypokalaemic effects of acetazolamide, loop diuretics and thiazide diureticsVaccines: high dose corticosteroids can impair immune response to vaccines – avoid concomitant use with live vaccines

    ADMINISTRATION

    Reconstition

    IV injection, IM injection: add 2 mL of sterile water for injection

    IV infusion

    : add not more than 2 mL water for injection, then add to 100–1000 mL (not less than 100 mL) glucose 5% or sodium chloride 0.9%

    Route

    IV injection,

    IV infusion

    , IM

    Rate of Administration

    IV bolus: 2–3 minutes

    Comments

    Minimum volume 100 mg in 50 mL. (UK Critical Care Group, Minimum Infusion Volumes for fluid restricted critically ill patients, 3rd Edition, 2006)

    OTHER INFORMATION

    Non-plasma protein bound hydrocortisone is removed by
  • HD                     :One study has shown that plasma clearance rates of hydrocortisone during haemodialysis were 30–63% higher than after dialysis. No recommendations exist to indicate dosing should be altered to take account of this



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs